Monday May 13
Are You Taking This Dangerous Drug?
On May 3, 2013, the FDA approved a Big Pharma Cartel founding member Merck drug Liptruzet.
Thu May 09, 2013
Merck's Liptruzet: A Cause For Shame?
I have discussed Vytorin several times before. The combination of Zetia , the cholesterol absorption inhibitor discovered at Schering-Plough, with Merck's simvastatin looked as if it should be a very effective cholesterol-lowering medication, but the real-world data have been consistently puzzling .
Mon May 06, 2013
FDA Approves Merck's New Combination...
Liptruzet , a combination drug developed by Merck that has been found to lower a patient's low-density lipoprotein cholesterol levels, has been approved by the US Food and Drug Administration .
Sun May 05, 2013
FDA Approves New Cholesterol-Cutting Combination Drug
The FDA has approved a new ezetimibe-atorvastatin tablet for lowering cholesterol in patients with primary or mixed hyperlipidemia, and in those with homozygous familial hypercholesterolemia.
Medical News Today
Liptruzet Approved By FDA To Cut Cholesterol, Despite Criticism By Cardiologists
Main Category: Cardiovascular / Cardiology Also Included In: Statins ; Cholesterol ; Regulatory Affairs / Drug Approvals Article Date: 05 May 2013 - 0:00 PDT Liptruzet, a cholesterol-lowering drug that combines Merck's Zetia with atorvastatin has been approved by the US FDA .
Fri May 03, 2013
FDA Approves Merck's LIPTRUZETa (ezetimibe and atorvastatin), a...
LIPTRUZET contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one of the most widely prescribed statins in the U.S.1 Once-daily LIPTRUZET treats two sources of cholesterol by inhibiting both the absorption of cholesterol in the digestive tract - through ezetimibe - and the production of cholesterol in ... (more)
FDA Approves Merck & Co., Inc.'s LIPTRUZET (ezetimibe and...
FDA Approves Merck & Co., Inc. 's LIPTRUZET , a New Product That Can Help Powerfully Lower LDL Cholesterol Staying up-to-date has never been simpler.
FDA approves Merck combination cholesterol lowering pill
The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday.
Wed May 01, 2013
Customer Interaction Solutions
Merck Announces First-Quarter 2013 Financial Results
Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2013.
Tue Apr 30, 2013
The Motley Fool
Will Merck's Dividends Continue to Produce Healthy Income for Investors?
Nauman is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.